An Open‐Label Single‐Arm Phase II Study of Treatment with Neoadjuvant S‐1 Plus Cisplatin for Clinical Stage III Squamous Cell Carcinoma of the Esophagus

LESSONS LEARNED: Two courses of neoadjuvant therapy using S‐1 plus cisplatin for clinical stage III esophageal squamous cell carcinoma did not achieve expected response rate according to endoscopic evaluation of primary tumors. Subsequent esophagectomy was safely performed. BACKGROUND: In Japan, eso...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncologist
Päätekijät: Kanda, Mitsuro, Koike, Masahiko, Iwata, Naoki, Shimizu, Dai, Tanaka, Chie, Hattori, Norifumi, Hayashi, Masamichi, Yamada, Suguru, Omae, Kenji, Nakayama, Goro, Kodera, Yasuhiro
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley & Sons, Inc. 2020
Aiheet:
Clinical Trial Results
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7648369/
https://ncbi.nlm.nih.gov/pubmed/32557987
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2020-0546
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia